Macquarie Group’s Vicarious Surgical RBOT Stock Holding History

Macquarie Group’s Portfolio RBOT Stock Details RBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-166	Closed	-$974	–	1861
2024 Q2	$974	Buy	+166	New	+$1.49K	﹤0.01%	1844

Other funds holding RBOT

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return

MAMHA

MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MAM

Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return

Macquarie Group's RBOT Position: Q3 2024 in Review

Macquarie Group sold out of Vicarious Surgical (RBOT) in Q3 2024, closing a stake of 166 shares — an estimated $974 sold.

Macquarie Group first reported a position in RBOT in Q2 2024 and held it in 1 quarter. The position peaked at $974 in Q2 2024. 34 funds tracked by Wall St. Rank hold RBOT as of Q3 2024.

Macquarie Group reported no remaining Vicarious Surgical position as of Q3 2024 after selling out during the quarter.
Macquarie Group sold 166 Vicarious Surgical shares in Q3 2024, an estimated $974.
Macquarie Group first reported a position in Vicarious Surgical in Q2 2024 and held it in 1 quarter.
Macquarie Group's Vicarious Surgical position peaked at $974 in Q2 2024.
34 funds tracked by Wall St. Rank held Vicarious Surgical as of Q3 2024.

Based on Macquarie Group's 13F filing for Q3 2024, filed 14 Nov 2024.